Related references
Note: Only part of the references are listed.Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study
Pasquale Pisapia et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
Laura Keller et al.
BRITISH JOURNAL OF CANCER (2021)
Regulation of PD-L1 expression in the tumor microenvironment
Ming Yi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients
Aliki Ntzifa et al.
SCIENTIFIC REPORTS (2021)
Role of circulating tumor cells in diagnosis of lung cancer: a systematic review and meta-analysis
Qingtao Zhao et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2021)
DNA methylome profiling of circulating tumor cells in lung cancer at single base-pair resolution
Lei Zhao et al.
ONCOGENE (2021)
Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patients
Liu Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Aneuploid Circulating Tumor Cells as a Predictor of Response to Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer
Miao Huang et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)
Emerging Lab-on-a-Chip Approaches for Liquid Biopsy in Lung Cancer: Status in CTCs and ctDNA Research and Clinical Validation
Angela Carvalho et al.
CANCERS (2021)
The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer
Claudia Freitas et al.
FRONTIERS IN ONCOLOGY (2021)
Combination of CT and telomerase+ circulating tumor cells improves diagnosis of small pulmonary nodules
Wen Zhang et al.
JCI INSIGHT (2021)
Circulating tumor cells as a promising target for individualized drug susceptibility tests in cancer therapy
Daniel J. Smit et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung Cancer
Lea Sinoquet et al.
CLINICAL CHEMISTRY (2021)
NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment
Estela Sanchez-Herrero et al.
MOLECULAR ONCOLOGY (2021)
Circulating Tumor Cell and Metabolites as Novel Biomarkers for Early-Stage Lung Cancer Diagnosis
Lingling Wan et al.
FRONTIERS IN ONCOLOGY (2021)
Complementary Sequential Circulating Tumor Cell (CTC) and Cell-Free Tumor DNA (ctDNA) Profiling Reveals Metastatic Heterogeneity and Genomic Changes in Lung Cancer and Breast Cancer
Say Li Kong et al.
FRONTIERS IN ONCOLOGY (2021)
Androgen Receptor Splice Variant, AR-V7, as a Biomarker of Resistance to Androgen Axis-Targeted Therapies in Advanced Prostate Cancer
Tian Zhang et al.
CLINICAL GENITOURINARY CANCER (2020)
Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
Peter T. Harrison et al.
SEMINARS IN CANCER BIOLOGY (2020)
An Integrated Microfluidic Chip and Its Clinical Application for Circulating Tumor Cell Isolation and Single-Cell Analysis
Mingxin Xu et al.
CYTOMETRY PART A (2020)
Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics
Edward Geeurickx et al.
MOLECULAR ASPECTS OF MEDICINE (2020)
Circulating Tumor Cells Are Associated with Recurrent Disease in Patients with Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy
Melissa A. Frick et al.
CLINICAL CANCER RESEARCH (2020)
Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer
Guo-Chen Duan et al.
ONCOTARGETS AND THERAPY (2020)
High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients
Mina Zeinali et al.
CANCERS (2020)
Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages
Nicolas Guibert et al.
EUROPEAN RESPIRATORY REVIEW (2020)
Molecular profiling for precision cancer therapies
Eoghan R. Malone et al.
GENOME MEDICINE (2020)
Identification of circulating tumor cells using 4-color fluorescence in situ hybridization: Validation of a noninvasive aid for ruling out lung cancer in patients with low-dose computed tomography-detected lung nodules
Ruth L. Katz et al.
CANCER CYTOPATHOLOGY (2020)
The significance of epidermal growth factor receptor uncommon mutations in non-small cell lung cancer: A systematic review and critical appraisal
Valerio Gristina et al.
CANCER TREATMENT REVIEWS (2020)
Continuous Microfluidic Purification of DNA Using Magnetophoresis
Ying Xu et al.
MICROMACHINES (2020)
Understanding the role of phenotypic switching in cancer drug resistance
Einar Bjarki Gunnarsson et al.
JOURNAL OF THEORETICAL BIOLOGY (2020)
Detection of PD-L1 Expression and Its Clinical Significance in Circulating Tumor Cells from Patients with Non-Small-Cell Lung Cancer
Yuxin Cheng et al.
CANCER MANAGEMENT AND RESEARCH (2020)
KRAS mutations testing in non-small cell lung cancer: the role of Liquid biopsy in the basal setting
Mariantonia Nacchio et al.
JOURNAL OF THORACIC DISEASE (2020)
Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study
Charles-Hugo Marquette et al.
Lancet Respiratory Medicine (2020)
Optimization of the Enrichment of Circulating Tumor Cells for Downstream Phenotypic Analysis in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1 Immunotherapy
Maria A. Papadaki et al.
CANCERS (2020)
The Use of Three-Dimensional DNA Fluorescent In Situ Hybridization (3D DNA FISH) for the Detection of Anaplastic Lymphoma Kinase (ALK) in Non-Small Cell Lung Cancer (NSCLC) Circulating Tumor Cells
Arutha Kulasinghe et al.
CELLS (2020)
Ex Vivo Expansion and Drug Sensitivity Profiling of Circulating Tumor Cells from Patients with Small Cell Lung Cancer
Hsin-Lun Lee et al.
CANCERS (2020)
A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity
Kathryn L. Simpson et al.
NATURE CANCER (2020)
Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer
Joanna Kapeleris et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Circulating tumor DNA: Where are we now? A mini review of the literature
Gliceida Maria Galarza Fortuna et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2020)
Application of exosomes as liquid biopsy in clinical diagnosis
Biting Zhou et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
A lab-on-a-disc platform enables serial monitoring of individual CTCs associated with tumor progression during EGFR-targeted therapy for patients with NSCLC
Minji Lim et al.
THERANOSTICS (2020)
Detection of circulating tumor cells in patients with lung cancer using metallic micro-cavity array filter: A pilot study
Hideo Ichimura et al.
MOLECULAR AND CLINICAL ONCOLOGY (2020)
Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo
Zujun Que et al.
CANCER CELL INTERNATIONAL (2019)
Heterogeneous Expression of Programmed Death Receptor-ligand 1 on Circulating Tumor Cells in Patients With Lung Cancer
Yasuhiro Koh et al.
CLINICAL LUNG CANCER (2019)
Molecular Analysis of Plasma From Patients With ROS1-Positive NSCLC
Ibiayi Dagogo-Jack et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX Study
D. Ross Camidge et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Neutrophils escort circulating tumour cells to enable cell cycle progression
Barbara Maria Szczerba et al.
NATURE (2019)
PD-L1 Expression in Circulating Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small Cell Lung Cancer
Yang Wang et al.
SCIENTIFIC REPORTS (2019)
Phenotypic Characterization of Circulating Lung Cancer Cells for Clinically Actionable Targets
Arutha Kulasinghe et al.
CANCERS (2019)
Isolation of circulating tumor cells in non-small-cell-lung-cancer patients using a multi-flow microfluidic channel
Jian Zhou et al.
MICROSYSTEMS & NANOENGINEERING (2019)
Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases
Tania Mamdouhi et al.
CANCER AND METASTASIS REVIEWS (2019)
Early Detection of Recurrence in Patients With Locally Advanced Non-Small-Cell Lung Cancer via Circulating Tumor Cell Analysis
Chimbu Chinniah et al.
CLINICAL LUNG CANCER (2019)
The Roles of MicroRNA in Lung Cancer
Kuan-Li Wu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The diagnostic value of circulating tumor cells and ctDNA for gene mutations in lung cancer
Mengyuan Lyu et al.
ONCOTARGETS AND THERAPY (2019)
Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients
Silvina Ribeiro-Samy et al.
SCIENTIFIC REPORTS (2019)
Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer
Yang Li et al.
CANCER MEDICINE (2019)
Monitoring of circulating tumor DNA and its aberrant methylation in the surveillance of surgical lung Cancer patients: protocol for a prospective observational study
Guannan Kang et al.
BMC CANCER (2019)
The potential of monitoring treatment response in non-small cell lung cancer using circulating tumour cells
Marianna Gallo et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2019)
Five-Year Overall Survival for Patients With Advanced Non-Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study
Edward B. Garon et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients
Heather Scharpenseel et al.
SCIENTIFIC REPORTS (2019)
Circulating Tumor Cell cluster phenotype allows monitoring response to treatment and predicts survival
Ajay Balakrishnan et al.
SCIENTIFIC REPORTS (2019)
Comprehensive analysis of EGFR T790M detection by ddPCR and ARMS-PCR and the effect of mutant abundance on the efficacy of osimertinib in NSCLC patients
Yue Li et al.
JOURNAL OF THORACIC DISEASE (2019)
Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors
Menno Tamminga et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
Melanie Janning et al.
CANCERS (2019)
PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer
Yariswamy Manjunath et al.
CANCERS (2019)
Circulating Tumor Cell PD-L1 Expression as Biomarker for Therapeutic Efficacy of Immune Checkpoint Inhibition in NSCLC
Vera Kloten et al.
CELLS (2019)
Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non-Small-Cell Lung Cancer
Emma Pailler et al.
CLINICAL CANCER RESEARCH (2019)
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer
C. R. Lindsay et al.
EUROPEAN JOURNAL OF CANCER (2019)
Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer
Stephanie N. Shishido et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Plasma next generation sequencing and droplet digital PCR-based detection of epidermal growth factor receptor (EGFR) mutations in patients with advanced lung cancer treated with subsequent-line osimertinib
Pei N. Ding et al.
THORACIC CANCER (2019)
Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment
Po-Lan Su et al.
CANCER MEDICINE (2019)
LBA5_PROsimertinib vs comparator EGFR-TKI as first-line treatment for EGFRm advanced NSCLC (FLAURA): Final overall survival analysis
S S Ramalingam et al.
ANNALS OF ONCOLOGY (2019)
Microfluidic Technologies for cfDNA Isolation and Analysis
Zheyun Xu et al.
MICROMACHINES (2019)
Single-Cell Analysis of Circulating Tumor Cells: How Far Have We Come in the -Omics Era?
Elisabetta Rossi et al.
FRONTIERS IN GENETICS (2019)
Detection of Circulating Tumor Cell Molecular Subtype in Pulmonary Vein Predicting Prognosis of Stage I-III Non-small Cell Lung Cancer Patients
Dingsi Dong et al.
FRONTIERS IN ONCOLOGY (2019)
Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeutics
Alice Lallo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
A 5-microRNA signature identified from serum microRNA profiling predicts survival in patients with advanced stage non-small cell lung cancer
Yajie Zhang et al.
CARCINOGENESIS (2019)
Current and future perspectives of liquid biopsies in genomics-driven oncology
Ellen Heitzer et al.
NATURE REVIEWS GENETICS (2019)
MYC Amplification as a Potential Mechanism of Primary Resistance to Crizonib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report
Karim Rihawi et al.
TRANSLATIONAL ONCOLOGY (2019)
Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients
Eirini Papadopoulou et al.
PLOS ONE (2019)
Applying circulating tumor DNA methylation in the diagnosis of lung cancer
Lei Li et al.
PRECISION CLINICAL MEDICINE (2019)
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer
Angela Listi et al.
TRANSLATIONAL CANCER RESEARCH (2019)
Cancer prevention and screening: the next step in the era of precision medicine
Holli A. Loomans-Kropp et al.
NPJ PRECISION ONCOLOGY (2019)
The emerging treatment landscape of targeted therapy in non-small-cell lung cancer
Min Yuan et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Next-generation sequencing in liquid biopsy: cancer screening and early detection
Ming Chen et al.
HUMAN GENOMICS (2019)
Detection of Plasma EGFR Mutations in NSCLC Patients with a Validated ddPCR Lung cfDNA Assay
Qiao-mei Guo et al.
JOURNAL OF CANCER (2019)
False-positive screens and lung cancer risk in the National Lung Screening Trial: Implications for shared decision-making
Paul F. Pinsky et al.
JOURNAL OF MEDICAL SCREENING (2018)
Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device
Bee Luan Khoo et al.
NATURE PROTOCOLS (2018)
Microfluidics Based Point-of-Care Diagnostics
Chandra M. Pandey et al.
BIOTECHNOLOGY JOURNAL (2018)
Circulating Tumor Cells Accurately Predicting Progressive Disease After Treatment in a Patient with Non-small Cell Lung Cancer Showing Response on Scans
Crista E. Horton et al.
ANTICANCER RESEARCH (2018)
Exosomes in lung cancer diagnosis and treatment. From the translating research into future clinical practice
Christos Masaoutis et al.
BIOCHIMIE (2018)
Exosome-Based Detection of EGFR T790M in Plasma from Non-Small Cell Lung Cancer Patients
Elena Castellanos-Rizaldos et al.
CLINICAL CANCER RESEARCH (2018)
Epithelial Mesenchymal Transition in Tumor Metastasis
Vivek Mittal
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)
TRACERx: Tracking tumor evolution to impact the course of lung cancer
Marcelo Vailati Negrao et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2018)
Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR- Mutated NSCLC
Anna Buder et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naive Patients With Advanced NSCLC
A. Lisberg et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Molecular Detection of EMT Markers in Circulating Tumor Cells from Metastatic Non-Small Cell Lung Cancer Patients: Potential Role in Clinical Practice
Annalisa Milano et al.
ANALYTICAL CELLULAR PATHOLOGY (2018)
Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer
Manjima Dhar et al.
SCIENTIFIC REPORTS (2018)
Combined use of EpCAM and FRa enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer
Luojun Chen et al.
SCIENTIFIC REPORTS (2018)
ALK-rearrangement in non-small-cell lung cancer (NSCLC)
Xue Du et al.
THORACIC CANCER (2018)
Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis
Shrujal Baxi et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis
Shrujal Baxi et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
The role of liquid biopsy in predicting post-operative recurrence of non-small cell lung cancer
Hengrui Liang et al.
JOURNAL OF THORACIC DISEASE (2018)
Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer
Galatea Kallergi et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
ctDNA and CTCs in Liquid Biopsy - Current Status and Where We Need to Progress
Martin H. D. Neumann et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2018)
Highly sensitive and specific real-time PCR by employing serial invasive reaction as a sequence identifier for quantifying EGFR mutation abundance in cfDNA
Zheng Xiang et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2018)
Analysis of single circulating tumor cells (CTCs) to identify resistance mutations to ALK-inhibitors in both ALK-gene and bypass oncogenic pathways.
Emma Pailler et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Assessment of the Mutational Status of NSCLC Using Hypermetabolic Circulating Tumor Cells
Matteo Turetta et al.
CANCERS (2018)
The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer
Joanna Kapeleris et al.
FRONTIERS IN ONCOLOGY (2018)
Survival Mechanisms and Influence Factors of Circulating Tumor Cells
Wen-Chao Wang et al.
BIOMED RESEARCH INTERNATIONAL (2018)
The prognostic significance of circulating tumor cells in head and neck and non-small-cell lung cancer
Arutha Kulasinghe et al.
CANCER MEDICINE (2018)
Circulating tumor DNA as prognostic markers for late stage NSCLC with bone metastasis
Jiguang Jia et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2018)
Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma
A. K. Krug et al.
ANNALS OF ONCOLOGY (2018)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
Serum MicroRNA-150 Predicts Prognosis for Early-Stage Non-Small Cell Lung Cancer and Promotes Tumor Cell Proliferation by Targeting Tumor Suppressor Gene SRCIN1
Liren Zhang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Detection of PD-L1 in circulating tumor cells and white blood cells from patients with advanced non-small-cell lung cancer
M. Ilie et al.
ANNALS OF ONCOLOGY (2018)
Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?
Chiara Lazzari et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR-TKI resistance
Wenxian Wang et al.
CANCER MEDICINE (2017)
Recent Advances in Targeting ROS1 in Lung Cancer
Jessica J. Lin et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Checkpoint Inhibitors in Metastatic EGFR-Mutated Non-Small Cell Lung Cancer A Meta-Analysis
Chee Khoon Lee et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh et al.
NATURE (2017)
Search for liquid biopsy grail points the way to drug discovery and development gems
Chris Morrison
NATURE REVIEWS DRUG DISCOVERY (2017)
Enrichment and single-cell analysis of circulating tumor cells
Yanling Song et al.
CHEMICAL SCIENCE (2017)
Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
Aadel A. Chaudhuri et al.
CANCER DISCOVERY (2017)
PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system?
Cristina Raimondi et al.
ONCOIMMUNOLOGY (2017)
Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers
Vasudha Murlidhar et al.
CANCER RESEARCH (2017)
The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613
Jordi Remon et al.
CLINICAL LUNG CANCER (2017)
Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer
Marianna Gallo et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2017)
Circulating Tumor Cells with Aberrant ALK Copy Number Predict Progression-Free Survival during Crizotinib Treatment in ALK-Rearranged Non-Small Cell Lung Cancer Patients
Emma Pailler et al.
CANCER RESEARCH (2017)
Challenges in circulating tumor cell detection by the CellSearch system
Kiki C. Andree et al.
MOLECULAR ONCOLOGY (2016)
Ultra-fast, label-free isolation of circulating tumor cells from blood using spiral microfluidics
Majid Ebrahimi Warkiani et al.
NATURE PROTOCOLS (2016)
Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer
M. Jamal-Hanjani et al.
ANNALS OF ONCOLOGY (2016)
Circulating Tumor Cells Detected in the Tumor-Draining Pulmonary Vein Are Associated with Disease Recurrence after Surgical Resection of NSCLC
Phil A. J. Crosbie et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
Glenwood Goss et al.
LANCET ONCOLOGY (2016)
Circulating tumor cell technologies
Meghaan M. Ferreira et al.
MOLECULAR ONCOLOGY (2016)
Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer
Catherine W. Bennett et al.
ONCOTARGET (2016)
Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer
Lynnette Fernandez-Cuesta et al.
EBIOMEDICINE (2016)
Lung cancer screening in patients with chronic obstructive pulmonary disease
Jessica Gonzalez et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
Circulating Tumor Cells in Diagnosing Lung Cancer: Clinical and Morphologic Analysis
Alfonso Fiorelli et al.
ANNALS OF THORACIC SURGERY (2015)
Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell-Free DNA from Patients with Advanced Non-Small Cell Lung Cancer
Guanshan Zhu et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
En Route to Metastasis: Circulating Tumor Cell Clusters and Epithelial-to-Mesenchymal Transition
Nicola Aceto et al.
TRENDS IN CANCER (2015)
An ultra-high-throughput spiral microfluidic biochip for the enrichment of circulating tumor cells
Majid Ebrahimi Warkiani et al.
ANALYST (2014)
Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes
D. J. E. Peeters et al.
BRITISH JOURNAL OF CANCER (2014)
Management of Acquired Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors in Patients With Advanced Non-Small Cell Lung Cancer
Adrian G. Sacher et al.
CANCER (2014)
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Nicola Aceto et al.
CELL (2014)
Sentinel Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
Marius Ilie et al.
PLOS ONE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
Edward F. Patz et al.
JAMA INTERNAL MEDICINE (2014)
Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment
Laura Muinelo-Romay et al.
CANCERS (2014)
Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomas
Alexis B. Cortot et al.
EUROPEAN RESPIRATORY REVIEW (2014)
Circulating cell free DNA: Preanalytical considerations
Safia El Messaoudi et al.
CLINICA CHIMICA ACTA (2013)
Microfluidics and Circulating Tumor Cells
Yi Dong et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
Neal I. Lindeman et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Tumour heterogeneity in the clinic
Philippe L. Bedard et al.
NATURE (2013)
A negative selection methodology using a microfluidic platform for the isolation and enumeration of circulating tumor cells
Benjamin P. Casavant et al.
METHODS (2013)
Inertial Focusing for Tumor Antigen-Dependent and -Independent Sorting of Rare Circulating Tumor Cells
Emre Ozkumur et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non-Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib
Elizabeth A. Punnoose et al.
CLINICAL CANCER RESEARCH (2012)
Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer
Tateaki Naito et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell et al.
LANCET ONCOLOGY (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer
A. Lecharpentier et al.
BRITISH JOURNAL OF CANCER (2011)
A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas
F. Farace et al.
BRITISH JOURNAL OF CANCER (2011)
Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker
Veronique Hofman et al.
CLINICAL CANCER RESEARCH (2011)
Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method
Veronique Hofman et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non-Small-Cell Lung Cancer
Matthew G. Krebs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R. Aberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody
Jason P. Gleghorn et al.
LAB ON A CHIP (2010)
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
S. J. Cohen et al.
ANNALS OF ONCOLOGY (2009)
Circulating Tumor Cells in Pulmonary Venous Blood of Primary Lung Cancer Patients
Yoshitomo Okumura et al.
ANNALS OF THORACIC SURGERY (2009)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Sunitha Nagrath et al.
NATURE (2007)
Lung cancer in never smokers - a different disease
Sophie Sun et al.
NATURE REVIEWS CANCER (2007)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Circulating deoxyribonucleic acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy
O Gautschi et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Share Paper
